Drugs / PG286
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT01789736 | Feb → Jun 2013 | ocular hypertension, open-angle glaucoma | Aerie Pharmaceuticals | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | PG286 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01789736 ↗ |
| Route | Other | “PG286 Ophthalmic Solution q.d. O.U.” NCT01789736 ↗ |